Selitrectinib Completed Phase 1 Trials for Solid Tumors Harboring NTRK Fusion Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03215511A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer